Antigen binding proteins
US11479607B2 · kind B2 · utility
0Cited by
0References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 19, 2021 |
| Grant date | Oct 25, 2022 |
| Priority date | — |
| Expiry date | Nov 19, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to compositions for treating CD96 mediated diseases, and related methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.